The journal of prevention of Alzheimer's disease | Journament

Journal Ranking

Unranked

Not Yet Ranked

Quality metrics need to be calculated to establish ranking.

Sign In to Calculate Scores Authentication required

The journal of prevention of Alzheimer's disease

Login or register to claim ownership or editorship of this journal.
Indexings
scopus ncbi
Short Name J Prev Alzheimers Dis
Abbreviated Name the journal of prevention of alzheimer's disease
ISSN 2426-0266
Aim and Scope
URL
Author Instructions

Publications Per Year

Recent Articles (8 total)

2019
Assessment of Clinical Meaningfulness of Endpoints in the Generation Program by the Insights to Model Alzheimer's Progression in Real Life (iMAP) Study
Graf, A.
Vol. 6 , pp. 85-89
176 views DOI
2024
Longitudinal Evolution of Financial Capacity and Cerebral Tau and Amyloid Burden in Older Adults with Normal Cognition or Mild Cognitive Impairment.
Mimmack, K J;Sprague, E H;Amariglio, R E;Vannini, P;Marshall, G A;
Vol. 11 , No. 4 , pp. 966-974
74 views DOI Abstract
2024
Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies.
Sperling, R A;Donohue, M C;Rissman, R A;Johnson, K A;Rentz, D M;Grill, J D;Heidebrink, J L;Jenkins, C;Jimenez-Maggiora, G;Langford, O;Liu, A;Raman, R;Yaari, R;Holdridge, K C;Sims, J R;Aisen, P S;
Vol. 11 , No. 4 , pp. 802-813
65 views DOI Abstract
2024
Longitudinal Trajectories of the Cognitive Function Index in the A4 Study.
Amariglio, R E;Grill, J D;Rentz, D M;Marshall, G A;Donohue, M C;Liu, A;Aisen, P S;Sperling, R A;
Vol. 11 , No. 4 , pp. 838-845
61 views DOI Abstract
2024
Safety Profile of a Cognitively Unimpaired Older Population with Elevated Cerebral Amyloid in a 4.5-Year Clinical Trial.
Yaari, R;Holdridge, K C;Mancini, M;Rafii, M S;Case, M;Battioui, C;Sims, J R;Aisen, P S;Sperling, R A;
Vol. 11 , No. 4 , pp. 857-868
59 views DOI Abstract
2024
Relationship between Plasma P-Tau217 and Amyloid PET in Racial and Ethnic Underrepresented Groups (RE-URG) Compared with Non RE-URG in LEARN and A4.
Molina-Henry, D;Langford, O;Donohue, M C;Raman, R;Aisen, P;Johnson, K A;Rissman, R A;Sperling, R;
Vol. 11 , No. 4 , pp. 831-837
54 views DOI Abstract
2024
Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 Study.
Papp, K V;Maruff, P;Rentz, D M;Donohue, M C;Liu, A;Aisen, P S;Sperling, R A;
Vol. 11 , No. 4 , pp. 846-856
52 views DOI Abstract
2024
Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 Study.
Rentz, D M;Rosenberg, P B;Sperling, R A;Donohue, M C;Raman, R;Liu, A;Aisen, P S;
Vol. 11 , No. 4 , pp. 814-822
51 views DOI Abstract
0
Overall
Not Rated
0
0
0
0
0
0
0
0
0
0
0
Journament